Iñaki Etxeberria

15PUBLICATIONS
66CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 22, 2025
CAR-engineered lymphocyte persistence is governed by a FAS ligand-FAS autoregulatory circuit.

Fei Yi, Tal Cohen, Natalie Zimmerman

|Feb 19, 2025
Tumour-wide RNA splicing aberrations generate actionable public neoantigens.

Darwin W Kwok, Nicholas O Stevers, Iñaki Etxeberria

|Mar 11, 2024
CAR-engineered lymphocyte persistence is governed by a FAS ligand/FAS auto-regulatory circuit.

Fei Yi, Tal Cohen, Natalie Zimmerman

|Dec 08, 2022
Intratumoral Gene Transfer of mRNAs Encoding IL12 in Combination with Decoy-Resistant IL18 Improves Local and Systemic Antitumor Immunity.

Assunta Cirella, Elixabet Bolaños, Claudia Augusta Di Trani

|Jun 30, 2022
A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1β.

Irene Olivera, Rebeca Sanz-Pamplona, Elixabet Bolaños

|Apr 28, 2022
Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA.

Smita S Chandran, Jiaqi Ma, Martin G Klatt

Pageof 3

Frequent Collaborators

6 joint publications

Pedro Berraondo

5 joint publications

Álvaro Teijeira

4 joint publications

Ignacio Melero

4 joint publications

Christopher A Klebanoff